Harnessing Predictive Enrichment Strategies for ARDS Clinical Trials; Past, Present & Future

Time: 1:25 pm
day: Day One


  • Understanding and leveraging heterogeneity within the syndrome of ARDS to prospectively identify treatment-responsive subtypes: what have we learned?
  • Divulging the challenges of rapid identification of ARDS subphenotypes of interest
  • Navigating matching biomarker credentials to trial design